James Balmford1, Jens A Leifert2, Cornelia Schulz3, Mirjam Elze4, Andreas Jaehne5. 1. Präventionsteam (PT) des Tumorzentrums, Universitätsklinikum Freiburg, Freiburg, Germany. Electronic address: James.Balmford@cancervic.org.au. 2. Präventionsteam (PT) des Tumorzentrums, Universitätsklinikum Freiburg, Freiburg, Germany; Department of Internal Medicine, Breisgauklinik, Bad Krozingen, Germany. 3. Präventionsteam (PT) des Tumorzentrums, Universitätsklinikum Freiburg, Freiburg, Germany. 4. Department of Thoracic Surgery, Universitätsklinikum Freiburg, Freiburg, Germany. 5. Präventionsteam (PT) des Tumorzentrums, Universitätsklinikum Freiburg, Freiburg, Germany; Department of Psychiatry & Psychotherapy, Universitätsklinikum Freiburg, Freiburg, Germany.
Abstract
OBJECTIVE: Hospitalized smokers are often highly motivated to quit and receptive to assistance. There are few published accounts of hospital-based smoking cessation programmes implemented outside of a trial setting, particularly outside North America. We describe the implementation and effectiveness of a dedicated smoking cessation service in Freiburg, Germany. METHODS: Measures of implementation (e.g. number of patients referred and consenting to participate, receipt of post-discharge support) and effectiveness are presented. RESULTS: In the first 2 years of the service, 1432 patients were referred. Over half (55.3%) of counselled smokers agreed to participate. Sustained abstinence for 6 months was achieved by 28.0% (missing cases coded as smokers), whereas 7-day point prevalence rates were between 30 and 35% at 3, 6 and 12 months. Those who received 4+ post-discharge calls were more likely to achieve sustained abstinence, as were older smokers, those with higher self-efficacy, and cardiovascular patients. CONCLUSION: Hospitalized patients in Germany are receptive to the offer of bedside counselling and to phone support post-discharge, and success rates are comparable to those achieved in other countries. PRACTICE IMPLICATIONS: The findings argue strongly for the routine identification of smokers upon hospital admission, and the availability of cessation support both during hospitalization and following discharge.
OBJECTIVE: Hospitalized smokers are often highly motivated to quit and receptive to assistance. There are few published accounts of hospital-based smoking cessation programmes implemented outside of a trial setting, particularly outside North America. We describe the implementation and effectiveness of a dedicated smoking cessation service in Freiburg, Germany. METHODS: Measures of implementation (e.g. number of patients referred and consenting to participate, receipt of post-discharge support) and effectiveness are presented. RESULTS: In the first 2 years of the service, 1432 patients were referred. Over half (55.3%) of counselled smokers agreed to participate. Sustained abstinence for 6 months was achieved by 28.0% (missing cases coded as smokers), whereas 7-day point prevalence rates were between 30 and 35% at 3, 6 and 12 months. Those who received 4+ post-discharge calls were more likely to achieve sustained abstinence, as were older smokers, those with higher self-efficacy, and cardiovascularpatients. CONCLUSION: Hospitalized patients in Germany are receptive to the offer of bedside counselling and to phone support post-discharge, and success rates are comparable to those achieved in other countries. PRACTICE IMPLICATIONS: The findings argue strongly for the routine identification of smokers upon hospital admission, and the availability of cessation support both during hospitalization and following discharge.
Authors: David A Katz; Kenda Stewart; Monica Paez; John Holman; Susan L Adams; Mark W Vander Weg; Catherine T Battaglia; Anne M Joseph; Marita G Titler; Sarah Ono Journal: Mil Med Date: 2016-04 Impact factor: 1.437
Authors: Titus J Brinker; Jonas Alfitian; Werner Seeger; David A Groneberg; Christof von Kalle; Alexander H Enk; Felix J F Herth; Michael Kreuter; Claudia M Bauer; Martina Gatzka; Janina L Suhre Journal: Int J Environ Res Public Health Date: 2018-08-04 Impact factor: 3.390